• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [535 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2010 NIHR Health Technology Assessment programme Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010 NIHR Health Technology Assessment programme A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin
2010 NIHR Horizon Scanning Centre (NIHR HSC) Sunitinib (Sutent) for locally advanced and/or metastatic non-small cell lung cancer - second line
2010 National Institute for Health and Care Excellence (NICE) Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. NICE technology appraisal guidance 192
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Gefitinib (Iressa) for the first-line treatment of non-small cell lung cancer
2010 Medical Advisory Secretariat (MAS) Epidermal Growth Factor Receptor Mutation (EGFR) testing for prediction of response to EGFR-targeting Tyrosine Kinase Inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer : an evidence-based and economic analysis
2010 NIHR Health Technology Assessment programme Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2010 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Rapid systematic review on radiotherapy in lung cancer]
2010 HTA Database, Centre for Reviews and Dissemination, University of York (CRD) The role of molecular-targeted agents involving maintenance therapy for non-small-cell lung cancer (Protocol for a systematic review)
2010 HAYES, Inc. ERCC1 expression analysis in Non-Small Cell Lung Cancer (NSCLC)
2010 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation
2010 National Institute for Health and Care Excellence (NICE) Percutaneous radiofrequency ablation for primary or secondary lung cancers. NICE interventional procedures guidance 372
2010 Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computed tomography (CT)
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Epidermal growth factor receptor mutation analysis in advanced non-small cell lung cancer: review of economic evaluations and framework for economic analyses
2009 HAYES, Inc. Positron Emission Tomography (PET) for monitoring and prognosis of lung cancer
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cetuximab (Erbitux) in EGFR-expressing Non-Small Cell Lung Cancer
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009 National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of relapsed small-cell lung cancer. NICE technology appraisal guidance 184
2009 National Institute for Health and Care Excellence (NICE) Pemetrexed for the first-line treatment of non-small-cell lung cancer. NICE technology appraisal guidance 181
2009 Committee for New Health Technology Assessment (CNHTA) [Radiofrequency (RF) ablation of primary and secondary lung malignancy]
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical- and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for locally advanced or metastatic non-small cell lung cancer - second line
2009 HAYES, Inc. Positron emission tomography (PET) for diagnosing and staging lung cancer
2009 HAYES, Inc. Positron emission tomography (PET) for treatment planning of lung cancer
2009 Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009 NIHR Health Technology Assessment programme Erlotinib for the treatment of relapsed non-small cell lung cancer
2009 HAYES, Inc. Combined positron emission tomography-computed tomography (PET-CT) for lung
2009 Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Lung cancer screening]
2009 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [New treatment with avastin and alimta for patients with non-small cell lung cancer]
2008 Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computer tomography (CT)
2008 National Institute for Health and Care Excellence (NICE) Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses. NICE interventional procedures guidance 254
2008 VA Technology Assessment Program (VATAP) Electromagnetic navigation bronchoscopy
2008 HAYES, Inc. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal lymph nodes in patients with lung cancer
2008 National Institute for Health and Care Excellence (NICE) Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal). NICE technology appraisal guidance 148
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2008 Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy for non-small cell lung cancer: a review of the clinical effectiveness
2008 NIHR Horizon Scanning Centre (NIHR HSC) Picoplatin for small cell lung cancer - second line
2008 The Netherlands Organisation for Health Research and Development (ZonMw) [Diagnosis and staging of lung cancer by endoscopic ultrasound guided fine needle aspiration (EUS-FNA)]
2008 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic-maintenance monotherapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Amrubicin for small cell lung cancer - relapsed and/or refractory, extensive disease
2008 Medical Services Advisory Committee (MSAC) Endobronchial ultrasound in the staging of lung cancer and the diagnosis of mediastinal masses of unknown origin
2008 HAYES, Inc. Epidermal growth factor receptor (EGFR) gene amplification analysis by fluorescence in situ hybridization (FISH) for predicting response to non-small cell lung cancer (NSCLC) drug therapy
2008 HAYES, Inc. Epidermal growth factor receptor (EGFR) sequence variant analysis for predicting response to non-small cell lung cancer (NSCLC) drug therapy
2008 HAYES, Inc. KRAS sequence variant analysis for non-small cell lung cancer (NSCLC)
2008 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Intravenous topotecan (Hycamtin®)
2008 HAYES, Inc. Radiofrequency ablation (RFA) of malignant pulmonary tumors in nonsurgical candidates
2008 HAYES, Inc. CyberKnife robotic radiosurgery system (Accuray Inc.) for lung cancer and other non-neurological indications
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2008 Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography for nine cancers (bladder, brain, cervical, kidney, ovarian, pancreatic, prostate, small cell lung, testicular)
2007 NIHR Horizon Scanning Centre (NIHR HSC) Lungscreen for lung cancer detection in high-risk patients: horizon scanning technology briefing
2007 Blue Cross Blue Shield Association (BCBS) Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer
2007 Andalusian Health Technology Assessment Area (AETSA) [Selective screening for lung cancer with chest CT]
2007 Blue Cross Blue Shield Association (BCBS) Off-label uses of Sorafenib and Sunitinib
2007 National Institute for Health and Care Excellence (NICE) Pemetrexed for the treatment of non-small-cell lung cancer. NICE technology appraisal guidance 124
2007 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with bevacizumab for advanced or metastatic non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for advanced non-small cell lung cancer
2007 NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer
2007 Medical Services Advisory Committee (MSAC) Endoscopic ultrasound and fine needle aspiration for lung cancer
2007 HAYES, Inc. Bevacizumab (Avastin) for non-small cell lung cancer
2007 Quality Improvement Scotland (NHS QIS ) Pemetrexed for the treatment of non-small-cell lung cancer
2007 Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computed tomography
2006 HAYES, Inc. Helical tomotherapy (TomoTherapy Hi-Art System) for non-small cell lung cancer (NSCLC)
2006 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews
2006 NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) for Non-Small Cell Lung Cancer: horizon scanning technology briefing
2006 NIHR Health Technology Assessment programme Pemetrexed for the treatment of relapsed non-small cell lung cancer
2006 Blue Cross Blue Shield Association (BCBS) Off-label uses of Bevacizumab: breast and lung cancer indications
2006 Agency for Healthcare Research and Quality (AHRQ) Management of small cell lung cancer
2006 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Electromagnetic navigation (SuperDimension/Bronchus(R)) and echo-endoscopy for the diagnosis of peripheral and mediastinal lesions - systematic review, expert panel
2006 HAYES, Inc. Conformal radiation therapy for lung cancer
2006 Canadian Agency for Drugs and Technologies in Health (CADTH) CT and MRI for selected clinical disorders: a systematic review of economic evaluations
2006 Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical and cost effectiveness of CT and MRI for selected clinical disorders: results of two systematic reviews
2006 HAYES, Inc. Neutron beam therapy for lung cancer
2006 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) 18-FDG positron emission tomography for non-small cell lung cancer: cost-effectiveness reports
2006 Blue Cross Blue Shield Association (BCBS) Special report: intensity-modulated radiation therapy for cancer of the breast or lung
2006 Adelaide Health Technology Assessment (AHTA) Epidermal growth factor receptor mutational assay for patients with non small-cell lung carcinoma
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) CT and MRI for selected clinical disorders: a systematic review of clinical systematic reviews
2005 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for non-small cell lung cancer (NSCLC) - horizon scanning review
2005 Institute for Clinical Effectiveness and Health Policy (IECS) Gefitinib for advanced lung cancer treatment
2005 Institute for Clinical Effectiveness and Health Policy (IECS) Erlotinib for the management of advanced lung cancer
2005 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment of erlotnib (Tarceva) for palliative treatment of non-small cell lung cancer]
2005 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Prophylactic antibiotics vs prophylactic G-CSF in prevention of febrile neuropenia in patients with a small cell bronchus carcinoma - primary research
2005 National Institute for Health and Care Excellence (NICE) Cryotherapy for malignant endobronchial obstruction. NICE interventional procedures guidance 142
2005 National Institute for Health and Care Excellence (NICE) Photodynamic therapy for localised inoperable endobronchial cancer. NICE interventional procedures guidance 137
2005 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) 18-FDG positron emission tomography for non-small cell lung cancer
2005 Health Council of the Netherlands Gezondheidsraad (GR) Asbestos diseases: lung cancer
2005 Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 1, gefitinib and erlotinib for non-small cell lung cancer
2004 NIHR Horizon Scanning Centre (NIHR HSC) Breath test for lung cancer screening - horizon scanning review
2004 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Assessment of photodynamic therapy using porfimer sodium for esophageal, bladder and lung cancers
2004 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Irradiation of the bronchuscarcinoma - primary research
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Gefitinib for inoperable or recurrent non-small cell lung cancer
2004 National Institute for Health and Care Excellence (NICE) Photodynamic therapy for advanced bronchial carcinoma. NICE interventional procedures guidance 87
2004 Agency for Healthcare Research and Quality (AHRQ) Positron emission testing for six cancers (brain, cervical, small cell lung, ovarian, pancreatic and testicular)
2004 Adelaide Health Technology Assessment (AHTA) ImageChecker CT-LN: a computer-aided system for the detection of lung cancer nodules
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Gefitinib for advanced or metastatic non-small cell lung cancer
2004 Adelaide Health Technology Assessment (AHTA) Breath test for lung cancer detection in high-risk patients
2004 Agency for Healthcare Research and Quality (AHRQ) Lung cancer screening: an update for the U.S. Preventive Services Task Force